| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Dorval Allison is a Chief Financial Officer at Voyager Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $6.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | PBYI Puma Biotechnology, Inc. | Director | Sell | 11,610 | $3.40 | $39,474.00 | -13.3% | +34.3% | - | |
| Jun 13, 2024 | PBYI Puma Biotechnology, Inc. | Director | Sell | 11,000 | $3.37 | $37,096.40 | -25.0% | -24.7% | +0.9% | |
| Jun 13, 2023 | PBYI Puma Biotechnology, Inc. | Director | Sell | 10,000 | $3.45 | $34,500.00 | -37.0% | -3.4% | +2.4% | |
| Feb 11, 2021 | VYGR Voyager Therapeutics, Inc. | Chief Financial Officer | Sell | 3,186 | $7.55 | $24,054.30 | -6.5% | - | - | |
| Jan 12, 2021 | VYGR Voyager Therapeutics, Inc. | Chief Financial Officer | Sell | 2,942 | $8.62 | $25,360.04 | -5.7% | - | - | |
| Jan 21, 2020 | VYGR Voyager Therapeutics, Inc. | Chief Financial Officer | Sell | 3,128 | $13.36 | $41,790.08 | -11.3% | - | - |